Cargando…
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
The earliest example of in vivo expression of exogenous mRNA is by direct intramuscular injection in mice without the aid of a delivery vehicle. The current state of the art for therapeutic nucleic acid delivery is lipid nanoparticles (LNP), which are composed of cholesterol, a helper lipid, a PEGyl...
Autores principales: | Kularatne, Ruvanthi N., Crist, Rachael M., Stern, Stephan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322927/ https://www.ncbi.nlm.nih.gov/pubmed/35890195 http://dx.doi.org/10.3390/ph15070897 |
Ejemplares similares
-
Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids
por: Kim, Dongyoon, et al.
Publicado: (2021) -
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression
por: Smith, Jill P., et al.
Publicado: (2023) -
Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells
por: Liu, Gary W., et al.
Publicado: (2023) -
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
por: Schlich, Michele, et al.
Publicado: (2021) -
New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery
por: Niculescu, Adelina-Gabriela, et al.
Publicado: (2021)